drugset / Trial / NCT04164797
Study of Endostar Combined With TP Regimen for Esophageal Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
a randomized controlled trial of endostar combined with TP regimen(liposomal paclitaxel-carboplatin) for chemoradiotherapy in esophageal squamous cell carcinoma(Ⅱ-Ⅲ)
Timeline
- Start
- 2019-11-25
- Primary completion
- 2021-07-13
- Completion
- 2021-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Endostar | Protein / enzyme biologic | 7.5 mg/m2 | — |
| Background | Carboplatin | Small molecule | 2 unknown | Intravenous |
| Background | Paclitaxel | Small molecule | 50 mg/m2 | Intravenous |